SCHEMBL9956124

SCHEMBL9956124

CNC(C)S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
CA2 P00918 6/20 0.45
CA1 P00915 5/20 0.45
MMP2 P08253 2/20 0.45
MMP1 P03956 1/20 0.45
MMP9 P14780 1/20 0.45
MMP8 P22894 1/20 0.45
MMP13 P45452 1/20 0.45
CA9 Q16790 5/20 0.45
CA12 O43570 4/20 0.45
CA7 P43166 2/20 0.45
CA3 P07451 1/20 0.45
CA6 P23280 1/20 0.45
CA5A P35218 1/20 0.45
CA5B Q9Y2D0 1/20 0.45
GBA1 P04062 1/20 0.44
TLR9 Q9NR96 1/20 0.43
ALDH1A1 P00352 8/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL680246 0.85 GAA (0.50) GAASMN1; SMN2CA2CA1MMP2
SCHEMBL3442044 0.79 TLR9 (0.44) GAASMN1; SMN2CA2CA1MMP2
SCHEMBL1149214 0.78 GAA (0.56) GAASMN1; SMN2CA2CA1MMP2
SCHEMBL178444 0.78 GAA (0.56) GAASMN1; SMN2CA2CA1MMP2
SCHEMBL30896660 0.78 GAA (0.56) GAASMN1; SMN2CA2CA1MMP2
SCHEMBL9385444 0.76 GAA (0.54) GAASMN1; SMN2CA2CA1MMP2
SCHEMBL26343853 0.75 GAA (0.59) GAASMN1; SMN2CA2CA1MMP2
SCHEMBL15478776 0.74 GAA (0.52) GAASMN1; SMN2CA2CA1MMP2
SCHEMBL7092154 0.74 GAA (0.52) GAASMN1; SMN2CA2CA1MMP2
SCHEMBL13367643 0.74 GAA (0.52) GAASMN1; SMN2CA2CA1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012085857-A1 3,8-DIAZA-BICYCLO[4.2.0]OCT-3-YL AMIDES ACTELION PHARMACEUTICALS LTD (CH) 2012-06-28 WO disclosed
WO-2012085852-A1 3,8-DIAZA-BICYCLO[4.2.0]OCT-8-YL AMIDES ACTELION PHARMACEUTICALS LTD (CH) 2012-06-28 WO disclosed